Table of Contents
Chapter 1. Executive Summary
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D and Designing
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Review
Chapter 6. Global Cancer Diagnostics Market, by Type
6.1 Overview
6.2 Imaging Testing
6.2.1 Magnetic Resonance Imaging (MRI)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.2 Computed Tomography (CT)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.3 Positron Emission Tomography (PET)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.3.1 Standalone Positron Emission Tomography
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.3.2 Hybrid Positron Emission Tomography
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.4 Mammography
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6. 2.5 Ultrasound
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.3 Biomarkers Testing
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.3.1 Protein Biomarker
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.2 Genetic Biomarker
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.3 Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4 In Vitro Diagnostic Testing
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.1 Polymerase Chain Reaction (PCR)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.2 In Situ Hybridization (ISH)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.3 Immunohistochemistry Testing (IHC)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.4 Next-Generation Sequencing Testing (NGS)
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.5 Microarrays
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.6 Flow Cytometry
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.5 Molecular Diagnostics
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4.6 Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.5 Biopsy
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.5.1 Needle Biopsy
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.5.2 Bone Marrow Biopsy
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.6 Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
Chapter 7. Global Cancer Diagnostics Market, by Application
7.1 Overview
7.2 Lung Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.3 Breast Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.4 Colorectal Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.5 Melanoma Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.6 Prostate Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.7 Liver Cancer
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.8 Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
Chapter 8. Global Cancer Diagnostics Market, by End User
8.1 Overview
82 Diagnostic Center
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.3 Hospitals and Clinics
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.4 Research Institutes
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8.5 Others
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
Chapter 9. Global Cancer Diagnostics Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10 Company Landscape
10.1 Overview
10.2 Competitive Analysis
Chapter 11. Company Profile
11.1 Exact Sciences Corporation
11.1.1 Company Overview
11.1.2 Products/Services Offered
11.1.3 Financial Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategies
11.2 Arquer Diagnostics Ltd
11.2.1 Company Overview
11.2.2 Products/Services Offered
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategies
11.3 BioMark Diagnostics Inc.
11.3.1 Company Overview
11.3.2 Products/Services Offered
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.3.6 Key Strategies
11.4 Biotheranostics
11.4.1 Company Overview
11.4.2 Products/Services Offered
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.4.6 Key Strategies
11.5 Cancer Diagnostics, Inc.
11.5.1 Company Overview
11.5.2 Products/Services Offered
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
11.6 Agilent Technologies, Inc.
11.6.1 Company Overview
11.6.2 Products/Services Offered
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategies
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Overview
11.7.2 Products/Services Offered
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategies
11.8 Illumina, Inc.
11.8.1 Overview
11.8.2 Products/Services Offered
11.8.3 Financial Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategies
11.9 Becton, Dickinson and Company
11.9.1 Overview
11.9.2 Products/Services Offered
11.9.3 Financial Overview
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategies
11.10 GE Healthcare
11.10.1 Overview
11.10.2 Products/Services Offered
11.10.3 Financial Overview
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategies
11.11 QIAGEN N.V.
11.11.1 Overview
11.11.2 Products/Services Offered
11.11.3 Financial Overview
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategies
11.12 Abbott Laboratories, Inc.
11.12.1 Overview
11.12.2 Products/Services Offered
11.12.3 Financial Overview
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategies
11.13 Roche Diagnostics
11.13.1 Overview
11.13.2 Products/Services Offered
11.13.3 Financial Overview
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.13.6 Key Strategies
11.14 Siemens Healthcare
11.14.1 Overview
11.14.2 Products/Services Offered
11.14.3 Financial Overview
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.14.6 Key Strategies
11.15 Koninklijke Philips N.V.
11.15.1 Overview
11.15.2 Products/Services Offered
11.15.3 Financial Overview
11.15.4 Key Developments
11.15.5 SWOT Analysis
11.15.6 Key Strategies
11.16 Others
Chapter 12 Appendix
12.1 References
12.2 Related Reports
LIST OF TABLES
Table 1 Global Cancer Diagnostics Market Synopsis, 2022-2030
Table 2 Global Cancer Diagnostics Market Estimates and Forecast, 2022-2030 (USD Million)
Table 3 Global Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 4 Global Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 5 Global Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 6 Global Cancer Diagnostics Market, by Region, 2022-2030 (USD Million)
Table 7 Americas: Cancer Diagnostics Market, by Region, 2020 and 2025
Table 8 Americas: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 9 Americas: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 10 Americas: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 11 North America: Cancer Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 12 North America: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 13 North America: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 14 North America: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 15 US: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 16 US: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 17 US: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 18 Canada: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 19 Canada: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 20 Canada: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 21 Latin America: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 22 Latin America: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 23 Latin America: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 24 Europe: Cancer Diagnostics Market, by Region, 2022-2030 (USD Million)
Table 25 Europe: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 26 Europe: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 27 Europe: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 28 Western Europe: Cancer Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 29 Western Europe: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 30 Western Europe: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 31 Western Europe: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 32 Eastern Europe: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 33 Eastern Europe: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 34 Eastern Europe: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 35 Asia-Pacific: Cancer Diagnostics Market, by Country, 2022-2030 (USD Million)
Table 36 Asia-Pacific: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 37 Asia-Pacific: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 38 Asia-Pacific: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
Table 39 Middle East & Africa: Cancer Diagnostics Market, by Region, 2022-2030 (USD Million)
Table 40 Middle East & Africa: Cancer Diagnostics Market, by Type, 2022-2030 (USD Million)
Table 41 Middle East & Africa: Cancer Diagnostics Market, by Application, 2022-2030 (USD Million)
Table 42 Middle East & Africa: Cancer Diagnostics Market, by End User, 2022-2030 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure of the Global Cancer Diagnostics Market
Figure 3 Market Dynamics of the Global Cancer Diagnostics Market
Figure 4 Global Cancer Diagnostics Market Share, by Type, 2020 (%)
Figure 5 Global Cancer Diagnostics Market Share, by Type, 2020 (USD Million)
Figure 6 Global Cancer Diagnostics Market Share, by Application, 2020 (%)
Figure 7 Global Cancer Diagnostics Market Share, by Application, 2020 (USD Million)
Figure 8 Global Cancer Diagnostics Market Share, by End User, 2020 (%)
Figure 9 Global Cancer Diagnostics Market Share, by End User, 2020 (USD Million)
Figure 10 Global Cancer Diagnostics Market Share, by Region, 2020 (%)
Figure 11 Americas: Cancer Diagnostics Market Share, by Region, 2020 (%)
Figure 12 North America: Cancer Diagnostics Market Share, by Country, 2020 (%)
Figure 13 Europe: Cancer Diagnostics Market Share, by Region, 2020 (%)
Figure 14 Western Europe: Cancer Diagnostics Market Share, by Country, 2020 (%)
Figure 15 Asia-Pacific: Cancer Diagnostics Market Share, by Country, 2020 (%)
Figure 16 Middle East & Africa: Cancer Diagnostics Market Share, by Region, 2020 (%)
Figure 17 Global Cancer Diagnostics Market: Company Share Analysis, 2020 (%)
Figure 18 Exact Sciences Corporation: Key Financials
Figure 19 Exact Sciences Corporation: Segmental Revenue
Figure 20 Exact Sciences Corporation: Regional Revenue
Figure 21 Arquer Diagnostics Ltd: Key Financials
Figure 22 Arquer Diagnostics Ltd: Segmental Revenue
Figure 23 Arquer Diagnostics Ltd: Regional Revenue
Figure 24 BioMark Diagnostics Inc.: Key Financials
Figure 25 BioMark Diagnostics Inc.: Segmental Revenue
Figure 26 BioMark Diagnostics Inc.: Regional Revenue
Figure 27 Biotheranostics: Key Financials
Figure 28 Biotheranostics: Segmental Revenue
Figure 29 Biotheranostics: Regional Revenue
Figure 30 Cancer Diagnostics, Inc.: Key Financials
Figure 31 Cancer Diagnostics, Inc.: Segmental Revenue
Figure 32 Cancer Diagnostics, Inc.: Regional Revenue
Figure 33 Agilent Technologies, Inc.: Key Financials
Figure 34 Agilent Technologies, Inc.: Segmental Revenue
Figure 35 Agilent Technologies, Inc.: Regional Revenue
Figure 36 Thermo Fisher Scientific, Inc.: Key Financials
Figure 37 Thermo Fisher Scientific, Inc.: Segmental Revenue
Figure 38 Thermo Fisher Scientific, Inc.: Regional Revenue
Figure 39 Illumina, Inc.: Key Financials
Figure 40 Illumina, Inc.: Segmental Revenue
Figure 41 Illumina, Inc.: Regional Revenue
Figure 42 Becton, Dickinson and Company: Key Financials
Figure 43 Becton, Dickinson and Company: Segmental Revenue
Figure 44 Becton, Dickinson and Company: Regional Revenue
Figure 45 GE Healthcare: Key Financials
Figure 46 GE Healthcare: Segmental Revenue
Figure 47 GE Healthcare: Regional Revenue
Figure 48 QIAGEN N.V.: Key Financials
Figure 49 QIAGEN N.V.: Segmental Revenue
Figure 50 QIAGEN N.V.: Regional Revenue
Figure 51 Abbott Laboratories, Inc.: Key Financials
Figure 52 Abbott Laboratories, Inc.: Segmental Revenue
Figure 53 Abbott Laboratories, Inc.: Regional Revenue
Figure 54 Roche Diagnostics: Key Financials
Figure 55 Roche Diagnostics: Segmental Revenue
Figure 56 Roche Diagnostics: Regional Revenue
Figure 57 Siemens Healthcare: Key Financials
Figure 58 Siemens Healthcare: Segmental Revenue
Figure 59 Siemens Healthcare: Regional Revenue
Figure 60 Koninklijke Philips N.V.: Key Financials
Figure 61 Koninklijke Philips N.V.: Segmental Revenue
Figure 62 Koninklijke Philips N.V.: Regional Revenue
